BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 32492579)

  • 1. Medication Use in Youth With Autism and Attention-Deficit/Hyperactivity Disorder.
    Rast JE; Anderson KA; Roux AM; Shattuck PT
    Acad Pediatr; 2021 Mar; 21(2):272-279. PubMed ID: 32492579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and treatment of mental, behavioral, and developmental disorders in children with co-occurring autism spectrum disorder and attention-deficit/hyperactivity disorder: A population-based study.
    Casseus M; Kim WJ; Horton DB
    Autism Res; 2023 Apr; 16(4):855-867. PubMed ID: 36644987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and correlates of psychotropic medication use in adolescents with an autism spectrum disorder with and without caregiver-reported attention-deficit/hyperactivity disorder.
    Frazier TW; Shattuck PT; Narendorf SC; Cooper BP; Wagner M; Spitznagel EL
    J Child Adolesc Psychopharmacol; 2011 Dec; 21(6):571-9. PubMed ID: 22166171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychiatric Comorbidities and Psychotropic Medication Use in Autism: A Matched Cohort Study with ADHD and General Population Comparator Groups in the United Kingdom.
    Houghton R; Liu C; Bolognani F
    Autism Res; 2018 Dec; 11(12):1690-1700. PubMed ID: 30380202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapy for the treatment of aggression in pediatric and adolescent patients with autism spectrum disorder comorbid with attention-deficit hyperactivity disorder: A questionnaire survey of 571 psychiatrists.
    Yamamuro K; Tsujii N; Ota T; Kishimoto T; Iida J
    Psychiatry Clin Neurosci; 2017 Aug; 71(8):554-561. PubMed ID: 28317224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Attention-Deficit/Hyperactivity Disorder with Medication in Children with Autism Spectrum Disorder With and Without Intellectual Disability: A DBPNet Study.
    Grater JE; Muniz EI; Silver EJ; Blum NJ; Shults J; Stein REK
    J Autism Dev Disord; 2023 Aug; 53(8):3144-3150. PubMed ID: 35633446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Timing of the Diagnosis of Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder.
    Miodovnik A; Harstad E; Sideridis G; Huntington N
    Pediatrics; 2015 Oct; 136(4):e830-7. PubMed ID: 26371198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medications for attention-deficit/hyperactivity disorder in individuals with or without coexisting autism spectrum disorder: analysis of data from the Swedish prescribed drug register.
    Johansson V; Sandin S; Chang Z; Taylor MJ; Lichtenstein P; D'Onofrio BM; Larsson H; Hellner C; Halldner L
    J Neurodev Disord; 2020 Dec; 12(1):44. PubMed ID: 33357227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and Correlates of Caregiver-Reported Mental Health Conditions in Youth With Autism Spectrum Disorder in the United States.
    Kerns CM; Rast JE; Shattuck PT
    J Clin Psychiatry; 2020 Dec; 82(1):. PubMed ID: 33356021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attention Deficit Hyperactivity Disorder Symptoms in Young Children with Autism Spectrum Disorder.
    Hong JS; Singh V; Kalb L
    Autism Res; 2021 Jan; 14(1):182-192. PubMed ID: 33073542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse Childhood Experiences and Family Resilience Among Children with Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder.
    Schneider M; VanOrmer J; Zlomke K
    J Dev Behav Pediatr; 2019; 40(8):573-580. PubMed ID: 31335581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inattention and hyperactivity/impulsivity among children with attention-deficit/hyperactivity-disorder, autism spectrum disorder, and intellectual disability.
    McClain MB; Hasty Mills AM; Murphy LE
    Res Dev Disabil; 2017 Nov; 70():175-184. PubMed ID: 28957735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychotropic Medication Use by Children with Autism Served in Publicly Funded Mental Health Settings.
    Caplan B; Chlebowski C; May G; Baker-Ericzén MJ; Connor W; Brookman-Frazee L
    J Dev Behav Pediatr; 2022 Jun-Jul 01; 43(5):252-261. PubMed ID: 34855690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of meeting 24-hour movement behavior guidelines with social and emotional function in youth with ASD/ADHD.
    Zhao M; Hou M; Herold F; Chen Y; Werneck AO; Block ME; Kramer AF; Taylor A; Cunha PM; Chaput JP; Falck RS; Owen N; Zou L
    J Affect Disord; 2024 Aug; 359():189-195. PubMed ID: 38768826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Processing speed as a marker to stimulant effect in clinical sample of children with high functioning autism spectrum disorder.
    Peled J; Cassuto H; Berger I
    Nord J Psychiatry; 2020 Apr; 74(3):163-167. PubMed ID: 31686565
    [No Abstract]   [Full Text] [Related]  

  • 16. Aberrant Behaviors and Co-occurring Conditions as Predictors of Psychotropic Polypharmacy among Children with Autism Spectrum Disorders.
    Logan SL; Carpenter L; Leslie RS; Garrett-Mayer E; Hunt KJ; Charles J; Nicholas JS
    J Child Adolesc Psychopharmacol; 2015 May; 25(4):323-36. PubMed ID: 25919445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased interoceptive accuracy in children with autism spectrum disorder and with comorbid attention deficit/hyperactivity disorder.
    Yang HX; Zhou HY; Li Y; Cui YH; Xiang Y; Yuan RM; Lui SSY; Chan RCK
    Autism Res; 2022 Apr; 15(4):729-739. PubMed ID: 35088528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychotropic Medication Prescribing for Youth at a Regional Autism Center.
    Gannon S; Abdelrazek A; Keller K; Rockhill C; Kim SJ
    J Child Adolesc Psychopharmacol; 2021 Dec; 31(10):653-658. PubMed ID: 34242065
    [No Abstract]   [Full Text] [Related]  

  • 19. Co-occurring attention-deficit/hyperactivity disorder and anxiety disorders differentially affect males and females with autism.
    Wodka EL; Parish-Morris J; Annett RD; Carpenter L; Dillon E; Michaelson J; Kim SH; Landa R; ; Kanne S
    Clin Neuropsychol; 2022 Jul; 36(5):1069-1093. PubMed ID: 34315336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-Response Effects of Long-Acting Liquid Methylphenidate in Children with Attention Deficit/Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD): A Pilot Study.
    Kim SJ; Shonka S; French WP; Strickland J; Miller L; Stein MA
    J Autism Dev Disord; 2017 Aug; 47(8):2307-2313. PubMed ID: 28474229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.